VeriMomtetrapeptide-29 argininamide est-il sûr pendant la grossesse ?
No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment found for tetrapeptide-29 argininamide, and no reproductive toxicity or endocrine activity reported in available peer-reviewed literature (PubMed) or ECHA/PubChem entries; therefore no evidence of reproductive hazard. Topical peptides are generally poorly absorbed but may have low measurable systemic absorption after repeated application, so exposure is scored as low (1). Sources checked: ECHA Annex VI, SCCS/CIR lists, PubMed, ECHA dossiers, PubChem.
Pregnancy-safe products containing tetrapeptide-29 argininamide
Related ingredients
Frequently asked questions
- tetrapeptide-29 argininamide est-il sûr pendant la grossesse ?
- No harmonised CLP classification (ECHA Annex VI), no SCCS or CIR safety assessment found for tetrapeptide-29 argininamide, and no reproductive toxicity or endocrine activity reported in available peer-reviewed literature (PubMed) or ECHA/PubChem entries; therefore no evidence of reproductive hazard. Topical peptides are generally poorly absorbed but may have low measurable systemic absorption after repeated application, so exposure is scored as low (1). Sources checked: ECHA Annex VI, SCCS/CIR lists, PubMed, ECHA dossiers, PubChem.
- tetrapeptide-29 argininamide est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no reproductive or lactation-specific hazards identified in authoritative sources. Low but measurable systemic absorption from topical use is plausible, so exposure scored as low (1). Sources checked: ECHA Annex VI, CIR/SCCS, PubMed, PubChem, CosIng.
- tetrapeptide-29 argininamide est-il sûr pour la peau de bébé ?
- No data indicating infant-specific toxicity or harmonised classification. Because infant skin has higher permeability and the ingredient has potential for low systemic absorption in adults, exposure for 0–3 yr is increased by one category to moderate (2). No evidence to change hazard or mechanism scores. Sources checked: ECHA Annex VI, SCCS/CIR, PubMed, ECHA dossiers, CosIng, EWG.
- Comment VeriMom évalue-t-il tetrapeptide-29 argininamide ?
- VeriMom évalue tetrapeptide-29 argininamide à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à tetrapeptide-29 argininamide pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à tetrapeptide-29 argininamide basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.